5-MeO-DET (5-Methoxy-N,N-diethyltryptamine) is a synthetic psychedelic belonging to the tryptamine family, recognized for its strong psychoactive properties and its role in experimental research settings. While it shares similarities with other 5-substituted tryptamines, its unique pharmacological structure produces distinct effects that are still under investigation in scientific and chemical communities.

• It is derived from diethyltryptamine (DET) and modified with a methoxy group at the 5th position.

• The compound produces sensory distortion, euphoria, and time alteration in controlled studies.

• 5-MeO-DET has been referenced in chemical literature but lacks extensive clinical exploration.

• Structurally and functionally, it is closely related to other research tryptamines like 5-MeO-DMT and 5-MeO-MiPT.

• Most use cases involve receptor binding analysis and neurochemical research models.

• It’s sold as a reagent only and is not approved for any therapeutic or recreational use.

• Our product is offered for legal laboratory analysis only under qualified supervision.

Though both compounds share the 5-methoxy substitution, their effects, duration, and intensity differ significantly. Understanding these differences is essential for any research protocol or analytical modeling.

• 5-MeO-DET has a significantly longer active window (3–6 hours) than the fast-acting 5-MeO-DMT (10–30 minutes).

• While 5-MeO-DMT produces abrupt ego dissolution, 5-MeO-DET has a gradual onset and more prolonged peak phase.

• DET-based compounds like 5-MeO-DET are better suited for extended time-series observation studies.

• The altered states induced by 5-MeO-DET are described as semi-immersive rather than fully overwhelming.

• 5-MeO-DET often allows partial retention of ego, cognitive tracking, and verbal function, unlike its DMT counterpart.

• DMT derivatives are typically smoked or vaporized, while 5-MeO-DET in research is usually used in oral/synthetic setups.

• From a structural standpoint, both share indole backbones, but differ in alkyl substitutions affecting metabolic pathways.

The effects of 5-MeO-DET are generally characterized by intense sensory distortion, emotional shifts, and alterations in space-time perception. While not as overpowering as 5-MeO-DMT, it produces a rich and immersive psychedelic experience in controlled research environments. These effects vary depending on dose, method of administration, and individual sensitivity.

• Visual Distortions: Participants report geometric patterns, light auras, and fractal vision, particularly under closed-eye conditions.

• Auditory Modulation: Tones and external sounds may echo, stretch, or shift in pitch, commonly reported during mid-peak states.

• Time Dilation: Time may seem to slow, stop, or loop, offering a non-linear perception often studied in cognitive distortion models.

• Body Sensations: Many experience a warm, tingling sensation across the body, often compared to a “body buzz” or energetic rush.

• Ego Flexibility: Partial ego dissolution is observed in mid-to-high dose experiments, allowing subjects to detach from identity narratives without full loss of control.

• Emotional Lability: Fluctuations between euphoria, nostalgia, and deep introspection are commonly recorded in journals and field notes.

• Mental Imagery: Vivid imagination and dreamlike visuals occur, offering potential interest for consciousness and perception studies.

5-MeO-DET occupies a gray legal status globally, meaning its regulation varies depending on regional policies. It is not listed as a controlled substance in many jurisdictions, but may still fall under analogue laws or import restrictions.

• United States: Not scheduled federally, but could be considered an analogue of DET under the Federal Analogue Act.

• United Kingdom: Likely covered under the Psychoactive Substances Act 2016, which bans all non-approved psychoactives.

• European Union: Varies country by country; Germany and Sweden have regulatory restrictions; others do not yet list it.

• Canada: Not listed in the CDSA but could be interpreted as an analogue depending on intent and context.

• Australia: May fall under blanket psychedelic or tryptamine prohibitions in some territories.

• Asia & Africa: Mostly unregulated, but import/export is subject to customs interpretation and enforcement.

• Buyer Responsibility: Always verify your country’s legal position before placing an order. We do not provide legal advice or ship to banned regions.

When handled correctly in a laboratory setting, 5-MeO-DET is considered safe for qualified professionals conducting chemical or analytical research. However, it requires strict safety protocols to avoid unintended exposure.

• Use Lab-Grade Equipment: Handling must be performed with microbalances, sterile glassware, and isolation tools to prevent contamination.

• Personal Protective Gear: Gloves, lab coats, and safety goggles must be worn to avoid dermal or mucosal exposure.

• Avoid Inhalation: Even trace airborne particles can be absorbed through the respiratory tract. Work in a fume hood when necessary.

• Prevent Skin Contact: 5-MeO-DET can be active in sub-milligram doses; skin contact can lead to accidental absorption.

• No Human Testing: This compound is strictly not for self-administration or unsupervised use.

• Label Clearly: All containers must be marked with the chemical name, batch number, and hazard information.

• Dispose Properly: Unused materials should be disposed of via hazardous chemical waste services, not regular trash.

In research contexts, 5-MeO-DET is handled in ultra-low to moderate milligram quantities, depending on the experimental setup. All measurements must be performed using calibrated microgram balances to ensure precision and safety.

• Threshold Dose (Research Observation): 1–3 mg is typically used to observe basic physiological effects.

• Low Dose Range: 4–8 mg allows study of visual and cognitive impact without full psychedelic intensity.

• Common Mid-Level Dose: 8–14 mg offers consistent, reproducible data on time distortion and ego-related changes.

• High Dose: 15–20 mg+ may induce complex hallucinations and is used in high-tolerance studies.

• Oral Route: Most documented studies use oral administration in controlled, synthetic analog testing.

• Inter-subject Variability: Dosage response can vary greatly depending on metabolic factors, storage conditions, and compound stability.

• Important Note: We never recommend dosage for consumption; this information is for chemical and academic documentation only.

Maintaining chemical integrity is essential when storing 5-MeO-DET for long-term use. The compound is sensitive to moisture, heat, and light — all of which can degrade potency and stability.

• Ideal Temperature Range: Store at 15°C to 25°C (59°F to 77°F) in a cool, stable environment.

• Light Protection: Keep the substance in a dark container or opaque foil pouch to block UV exposure.

• Humidity Control: Moisture promotes hydrolysis and chemical degradation; always use desiccants in storage jars.

• Air Exposure: Use airtight, vacuum-sealed containers to minimize oxidation and maintain purity.

• Freezer Storage (Optional): For long-term archiving, low-humidity freezing (–10°C or lower) may be used, provided the container is moisture-sealed.

• Do Not Refrigerate Unsealed: Fridges often contain humidity, which can seep into packaging unless double-sealed.

• Shelf Life: Our product remains stable for up to 24 months under proper conditions.

Verifying the purity and identity of 5-MeO-DET is crucial to ensure that the material meets lab standards and that research outcomes are valid. We provide documented assurance of quality on every order.

• GC-MS Testing: Our compound is analyzed via Gas Chromatography–Mass Spectrometry, ensuring precise molecular breakdown.

• HPLC Validation: High-Performance Liquid Chromatography confirms both identity and purity beyond 99%.

• Certificate of Analysis (COA): Every batch can be accompanied by a COA upon request, detailing test methods, date, and findings.

• Visual Inspection: While not definitive, pure 5-MeO-DET typically appears as white to off-white crystalline powder with no discoloration or residue.

• Consistency Across Batches: Lab-grade 5-MeO-DET maintains uniform consistency in appearance and weight.

• No Filler or Binder Content: Our products contain no additives or excipients.

• Independent Verification: We encourage third-party testing for researchers who require separate authentication.

No. Psycho Plug supplies 5-MeO-DET strictly for research and chemical analysis. We do not condone, promote, or support unsupervised personal use or any form of human ingestion.

• Not for Human Consumption: The compound is labeled and sold exclusively for laboratory and analytical purposes.

• Ethical Research Protocols: Only certified institutions or researchers should handle this compound, following IRB-approved procedures.

• No Medical Claims: 5-MeO-DET is not approved for treating or diagnosing any condition.

• Legal Risks: Personal experimentation may lead to violations of analogue or controlled substance laws.

• Potential for Harm: Unsupervised use can result in adverse effects, psychological distress, or medical emergencies.

• Professional Use Only: Only trained individuals in a laboratory setting should be working with this substance.

• Void of Warranty if Misused: Any unauthorized or misuse of our product voids all purchase guarantees and protections.

The onset time for 5-MeO-DET depends on dose and route of administration. In general research models, it shows a relatively gradual onset compared to other tryptamines, which makes it easier to observe state transitions.

• Oral Onset Range: 30 to 60 minutes after administration in solution or capsule-based test models.

• Sublingual Onset: Anecdotal reports suggest 15–30 minutes onset when dissolved under the tongue, though this is rarely used in labs.

• Peak Window: Peak effects generally occur 90–120 minutes into the session.

• Gradual Escalation: The onset is more linear and less abrupt than compounds like 5-MeO-DMT.

• Ideal for Study Phases: This makes it suitable for mapping gradual neurological or perceptual changes.

• Metabolic Factors: Onset may vary based on liver enzyme activity and individual metabolism in research subjects.

• Formulation Impacts: Buffered or encapsulated forms may delay onset by 10–15 minutes compared to direct solution-based methods.

The duration of 5-MeO-DET’s effects is considered moderate compared to other psychedelics. In a laboratory or observational setting, the compound exhibits a sustained psychoactive phase that allows researchers to track and analyze changes in perception, cognition, and neurological response over time. This makes it especially suitable for prolonged research sessions without the abrupt crash or rapid tapering seen in fast-acting compounds like 5-MeO-DMT.

• Total Active Duration: Typically ranges from 3 to 6 hours, depending on dose and individual metabolism.

• Come-up Phase: Starts around 30–60 minutes after administration and builds gradually.

• Peak Phase: Observed between 1.5 to 3 hours post-intake, where the most intense effects are recorded.

• Comedown Phase: Gradual reduction in intensity between hour 4 and 6, often with lingering visual tracers or body sensations.

• Aftereffects: Some researchers note mood alterations, emotional afterglow, or sleep pattern shifts up to 12 hours post-session.

• Duration Consistency: The curve is predictable, making it useful for time-dependent psychological or cognitive studies.

• No Sudden Drop-offs: Unlike some psychedelics, 5-MeO-DET tends not to induce sudden end-of-experience crashes.

While 5-MeO-DET is not currently approved for medical use, preliminary discussions in psychopharmacology suggest that it may hold value for understanding emotional release, trauma response, and altered states of consciousness. However, no peer-reviewed therapeutic trials currently validate its use in a clinical setting.

• Potential for Emotional Breakthroughs: Some qualitative reports indicate experiences of suppressed memory resurfacing and emotional catharsis under its influence.

• Self-reflective States: The introspective clarity provided by 5-MeO-DET in controlled environments could have implications for psychotherapy research.

• Mood Lifting Effects: Anecdotal findings point to temporary improvements in mood, suggesting value in mood disorder exploration.

• Ego Softening vs. Ego Loss: Unlike compounds like 5-MeO-DMT that trigger abrupt ego dissolution, 5-MeO-DET allows for introspective navigation with partial ego control.

• Potential Neurological Markers: Its interaction with serotonin receptors may help inform future studies on neuroplasticity or emotional processing.

• No Approved Studies Yet: There are no officially sanctioned therapeutic trials, so any discussion remains speculative and theoretical.

• Strictly For Research Use: Until clinical research is conducted, it must not be used or marketed for therapeutic applications.

Based on existing literature and anecdotal reports, 5-MeO-DET has no known physical dependency profile. It is not associated with cravings or withdrawal symptoms, making it unlikely to produce addiction in a physiological sense. However, psychological habituation is possible, particularly with unsupervised use.

• No Dopamine Binding: It does not significantly affect the brain’s reward or dopamine systems associated with addictive substances.

• Low Reinforcement Drive: Users often report that frequent use diminishes its appeal due to tolerance and intense effects.

• Rapid Tolerance Build-Up: Repeated use in short succession leads to diminished effects, which discourages daily or habitual use.

• Psychological Habituation: Like other psychedelics, some may over-rely on it for escapism or emotional release, creating behavioral dependence.

• No Withdrawal Symptoms: There are no known reports of physical symptoms upon cessation after repeated use.

• Risk of Overuse in Curiosity-Driven Settings: In non-research settings, a fascination with its effects could lead to repetitive usage cycles.

• Responsibility in Research: Laboratories should limit exposure frequency and ensure structured intervals between sessions.

In any controlled research or chemical study, mixing psychoactive compounds is strongly discouraged. Combining 5-MeO-DET with other substances can produce unpredictable interactions and invalidate research outcomes, or worse, pose safety risks if not carefully modeled.

• Unpredictable Synergy: 5-MeO-DET’s serotonergic activity can amplify the effects of other tryptamines or phenethylamines, making results erratic.

• Serotonin Syndrome Risk: Combining with MAO inhibitors, SSRIs, or other serotonergic compounds can dangerously increase serotonin levels.

• Compromised Data Integrity: Mixing compounds introduces too many variables, making controlled outcomes impossible to verify.

• Unknown Metabolic Interactions: Little research exists on how 5-MeO-DET metabolizes alongside other chemicals, increasing risk of adverse byproducts.

• No Published Combinatory Protocols: Reputable journals or academic sources do not document safe mixing procedures for 5-MeO-DET.

• Increased Psychological Stress: Reports suggest compound layering can trigger confusion, panic, or psychological overload.

• Single Compound Focus Preferred: Best practice in chemical research is to isolate substances to ensure clarity and reproducibility.

Proper safety protocols are essential when working with 5-MeO-DET in any environment. The compound is highly potent and requires controlled handling to prevent accidental exposure. All lab procedures should comply with local chemical safety regulations and best practices.

• Use of Personal Protective Equipment (PPE): Always wear nitrile gloves, protective eyewear, and a lab coat when handling the compound.

• Work in Controlled Ventilation: Utilize a chemical fume hood or laminar flow hood to prevent inhalation of fine powder particles.

• Avoid Cross-Contamination: Use dedicated tools and containers. Never reuse pipettes or scoops across multiple chemicals.

• Label Clearly: Storage containers should be accurately labeled with compound name, concentration, and hazard level.

• Prevent Skin Absorption: 5-MeO-DET may be active at very low doses; dermal exposure must be avoided at all costs.

• Secure Storage: When not in use, keep the substance locked away in climate-stable conditions with restricted access.

• Emergency Procedures: Labs should be equipped with eye wash stations, spill kits, and material safety data sheets (MSDS) for immediate reference.

When 5-MeO-DET is exposed to heat, moisture, or light for extended periods, its chemical integrity begins to degrade. This can lead to a reduction in potency, altered pharmacological properties, and increased risk of impurities, which can compromise the accuracy and reliability of any research findings.

• Visual Indicators: Degraded 5-MeO-DET may develop discoloration, clumping, or a yellowish tint compared to its usual white to off-white appearance.

• Reduced Efficacy: Breakdown of the active compound may result in diminished psychoactive or biochemical effects during testing.

• Formation of Unknown Byproducts: Decomposition may introduce unintended secondary compounds that interfere with experiments or cause false positives.

• Increased pH Sensitivity: Older or improperly stored samples may react more strongly with environmental moisture or oxygen.

• Shortened Shelf Life: Once exposed to degrading conditions, shelf life may drop to weeks rather than the standard 24-month duration.

• Inconsistent Research Results: Degradation makes experimental replication difficult, undermining scientific reliability.

• Proper Disposal Advised: If degradation is suspected, the compound should be discarded through proper chemical waste protocols.

Standard drug panels do not test for tryptamines like 5-MeO-DET. However, certain specialized tests can be used to identify it in biological samples under specific conditions. Its detection requires advanced forensic methods that are not commonly employed in routine employment or legal screenings.

• Not Included in 5-Panel or 10-Panel Tests: Typical workplace drug screens focus on opiates, amphetamines, cannabis, benzodiazepines, and cocaine.

• Requires Targeted Screening: Detection of 5-MeO-DET involves GC-MS or LC-MS/MS with specific tryptamine reference libraries.

• Short Detection Window: If consumed, the body metabolizes tryptamines rapidly, leading to a short timeframe for accurate trace detection.

• Legal Relevance Varies: Most testing agencies do not prioritize 5-MeO-DET unless part of a toxicology panel or forensic investigation.

• False Positives Unlikely: Its molecular structure does not mimic the markers used in tests for common controlled substances.

• Not Commonly Monitored: Law enforcement or sports authorities rarely screen for rare psychedelics unless suspected.

• Best Practice: Treat all chemical research compounds as traceable under ideal forensic conditions.

Expired or degraded 5-MeO-DET must be handled with care during disposal. Never discard it in regular trash or down the drain, as it can pose environmental or chemical risks. Disposal should follow hazardous waste protocols recognized by chemical safety standards.

• Use Licensed Chemical Waste Disposal Services: Partner with certified hazardous material handlers for proper collection and destruction.

• Do Not Flush: Water systems are not equipped to handle synthetic tryptamines, and disposal via plumbing is illegal in many regions.

• Neutralize if Required: Some labs deactivate residual compounds with chemical neutralization agents before discarding.

• Seal Securely: Package in original or sealed secondary containers labeled as expired research chemicals.

• Document the Disposal: Maintain logs of quantities disposed, dates, and methods used, especially in institutional environments.

• Follow Local Regulations: Compliance with state, federal, or international chemical waste guidelines is mandatory.

• Avoid Burning or Incineration: High temperatures can release toxic fumes if not handled in specialized incinerators.

Yes. At Psycho Plug, every batch of 5-MeO-DET is independently lab-tested, and we provide a Certificate of Analysis (COA) upon request to ensure full transparency and scientific validity for your research.

• Batch-Specific Reports: Each COA corresponds to a specific lot number and includes purity percentage, test methods, and lab information.

• Testing Methods Listed: COAs include whether GC-MS, HPLC, or FTIR was used to validate the compound’s structure and purity.

• Purity Data Provided: Our products consistently meet or exceed the ≥99% purity mark, as reflected in our documentation.

• Contaminant Checks: Reports highlight whether the sample contains solvents, heavy metals, or biological residues.

• Request at Checkout: COAs can be automatically emailed upon order confirmation or by contacting support.

• Supports Academic Integrity: Many universities and private labs require COAs to comply with internal review processes.

• Signed by Analysts: Each certificate is signed and dated by certified chemists at our partner labs.

Absolutely. We offer a 30-day return or replacement guarantee to ensure total satisfaction and peace of mind. If your 5-MeO-DET shipment is lost, damaged, delayed, or does not meet your expectations, we’ll make it right.

• 30-Day Coverage: From the delivery date, you have 30 days to initiate a return or claim a replacement.

• No Questions Asked: We honor refund or replacement requests promptly — no need to justify or argue.

• Lost Packages: If tracking shows non-delivery, we’ll ship a new unit immediately or refund your full amount.

• Damaged Items: If your package is tampered with or arrives unsealed, we replace it at no cost to you.

• Wrong Product: If you receive the wrong item, send us a picture, and we’ll correct it within 48 hours.

• Payment Refund Options: Refunds are processed via the original payment method (crypto, Zelle, CashApp, etc.).

• Live Support: Our customer service team is available 24/7 to help resolve any return-related issue.